\-\ Texto\\:\\ \ \(0\)\
\-\ obese\\ female\\ in\\ no\\ apparent\\ distress\\ with\\ facial\\ and\\ bilateral\\ upper\\ extremity\\ edema\\.\\ \\ wbc\\ \\=\\ 2\\.9\\ x103\\ per\\ \\&\\#956\\;l\\.\ \(0\)\
\-\ this\\ patient\\ was\\ treated\\ with\\ local\\ thrombolysis\\ via\\ catheter\\ infusion\\ of\\ tissue\\ plasminogen\\ activator\\ \\(tpa\\)\\ as\\ well\\ as\\ multiple\\ percutaneous\\ transluminal\\ angioplasties\\ \\(pta\\)\\ over\\ the\\ course\\ of\\ 3\\ days\\.\\ \\ ultimately\\ endovascular\\ mechanical\\ thrombectomy\\ in\\ combination\\ with\\ pta\\ yielded\\ the\\ final\\ result\\.\ \(0\)\
\-\ frontal\\ cxr\\ \\â\\€\\“\\ central\\ venous\\ catheter\\ placement\\ with\\ tip\\ in\\ the\\ region\\ of\\ the\\ svc\\.\\ \\ absent\\ right\\ breast\\ shadow\\ consistent\\ with\\ past\\ mastectomy\\.\\ \\ widened\\ superior\\ mediastinum\\,\\ right\\ greater\\ than\\ left\\,\\ in\\ the\\ region\\ of\\ the\\ azygos\\ vein\\.\\ \\ \ \(0\)\
\-\ axial\\ ct\\ w\\/contrast\\ at\\ the\\ level\\ of\\ the\\ aortic\\ arch\\ \\â\\€\\“\\ homogeneous\\ filling\\ defect\\ in\\ the\\ svc\\.\ \(0\)\
\-\ venography\\ \\(initial\\)\\ \\â\\€\\“\\ this\\ demonstrates\\ occlusion\\ of\\ the\\ right\\ brachiocephalic\\ vein\\ with\\ complete\\ absence\\ of\\ opacification\\ inferior\\ to\\ obstruction\\ as\\ well\\ as\\ opacification\\ of\\ a\\ dilated\\ azygos\\ vein\\ collateral\\.\ \(0\)\
\-\ venography\\ \\(final\\)\\ \\â\\€\\“\\ this\\ demonstrates\\ reconstitution\\ of\\ flow\\ through\\ the\\ right\\ brachiocephalic\\ vein\\ into\\ the\\ svc\\ without\\ backfilling\\ of\\ collateral\\ vessels\\.\ \(0\)\
\-\ svc\\ syndrome\\ secondary\\ to\\ central\\ catheter\\-related\\ venous\\ thrombosis\\.\ \(0\)\
\-\ given\\ radiographic\\ findings\\,\\ differential\\ considerations\\ would\\ include\\ lymphoma\\,\\ infectious\\ process\\,\\ non\\-infectious\\ granulomatous\\ disease\\ \\(sarcoid\\)\\,\\ and\\ venous\\ thrombosis\\.\\ \\ ct\\ confirms\\ thrombosis\\ in\\ the\\ svc\\ and\\ venography\\ confirms\\ consequent\\ svc\\ syndrome\\.\ \(0\)\
\-\ this\\ 43\\ yo\\ woman\\ presented\\ with\\ a\\ 5\\-day\\ history\\ of\\ bilateral\\ facial\\,\\ neck\\,\\ and\\ upper\\ extremity\\ swelling\\,\\ as\\ well\\ as\\ episodes\\ of\\ dizziness\\ and\\ syncope\\.\ \(0\)\
\-\ this\\ patient\\ was\\ diagnosed\\ with\\ poorly\\ differentiated\\ infiltrating\\ ductal\\ carcinoma\\ and\\ subsequently\\ treated\\ with\\ a\\ right\\ modified\\ radical\\ mastectomy\\ approximately\\ 4\\ months\\ prior\\ to\\ current\\ admission\\.\\ \\ a\\ right\\-sided\\ indwelling\\ central\\ catheter\\ had\\ been\\ in\\ place\\ for\\ approximately\\ 3\\.5\\ months\\ and\\ the\\ patient\\ was\\ status\\-post\\ 6\\ cycles\\ of\\ doxorubicin\\ and\\ cyclophosphamide\\ \\(ac\\)\\ chemotherapy\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ svc\\:\\ 0\\.10345875309040177\ \(0\)\
\-\ venography\\:\\ 0\\.0635478951159119\ \(0\)\
\-\ \\â\\€\\“\\:\\ 0\\.048373649363402486\ \(0\)\
\-\ pta\\:\\ 0\\.04036240975577439\ \(0\)\
\-\ azygos\\:\\ 0\\.04036240975577439\ \(0\)\
\-\ brachiocephalic\\:\\ 0\\.03981516839105974\ \(0\)\
\-\ vein\\:\\ 0\\.03889224304420273\ \(0\)\
\-\ catheter\\:\\ 0\\.03873573794956759\ \(0\)\
\-\ thrombosis\\:\\ 0\\.03460399950144382\ \(0\)\
\-\ mastectomy\\:\\ 0\\.03193615601058572\ \(0\)\
\-\ venous\\:\\ 0\\.02926212847601065\ \(0\)\
\-\ final\\:\\ 0\\.02899890443129266\ \(0\)\
\-\ confirms\\:\\ 0\\.02854624091163801\ \(0\)\
\-\ opacification\\:\\ 0\\.02845949045797552\ \(0\)\
\-\ collateral\\:\\ 0\\.028123981145363613\ \(0\)\
\-\ x103\\:\\ 0\\.027721756050209115\ \(0\)\
\-\ plasminogen\\:\\ 0\\.027721756050209115\ \(0\)\
\-\ activator\\:\\ 0\\.027721756050209115\ \(0\)\
\-\ angioplasties\\:\\ 0\\.027721756050209115\ \(0\)\
\-\ catheter\\-related\\:\\ 0\\.027721756050209115\ \(0\)\
\-\ central\\:\\ 0\\.02652482412132037\ \(0\)\
\-\ 956\\:\\ 0\\.025542047935240734\ \(0\)\
\-\ non\\-infectious\\:\\ 0\\.025542047935240734\ \(0\)\
\-\ 5\\-day\\:\\ 0\\.025542047935240734\ \(0\)\
\-\ as\\:\\ 0\\.02438825482819109\ \(0\)\
\-\ transluminal\\:\\ 0\\.02426700042546663\ \(0\)\
\-\ backfilling\\:\\ 0\\.02426700042546663\ \(0\)\
\-\ consequent\\:\\ 0\\.02426700042546663\ \(0\)\
\-\ facial\\:\\ 0\\.02336888047888239\ \(0\)\
\-\ tpa\\:\\ 0\\.02208729231049825\ \(0\)\
\-\ indwelling\\:\\ 0\\.02118263170530397\ \(0\)\
\-\ w\\/contrast\\:\\ 0\\.020812244800724147\ \(0\)\
\-\ reconstitution\\:\\ 0\\.020480922424441675\ \(0\)\
\-\ thrombectomy\\:\\ 0\\.020181204877887195\ \(0\)\
\-\ extremity\\:\\ 0\\.0196550878593864\ \(0\)\
\-\ cycles\\:\\ 0\\.019422833630035344\ \(0\)\
\-\ doxorubicin\\:\\ 0\\.019422833630035344\ \(0\)\
\-\ cyclophosphamide\\:\\ 0\\.019422833630035344\ \(0\)\
\-\ 2\\.9\\:\\ 0\\.019205874914667572\ \(0\)\
\-\ thrombolysis\\:\\ 0\\.019002923590335587\ \(0\)\
\-\ ac\\:\\ 0\\.019002923590335587\ \(0\)\
\-\ yielded\\:\\ 0\\.01881228012550403\ \(0\)\
\-\ syncope\\:\\ 0\\.018301214309473294\ \(0\)\
\-\ well\\:\\ 0\\.018236612763855197\ \(0\)\
\-\ status\\-post\\:\\ 0\\.01814778612026124\ \(0\)\
\-\ modified\\:\\ 0\\.018001496762918814\ \(0\)\
\-\ infusion\\:\\ 0\\.017599505028611\ \(0\)\
\-\ l\\.\\:\\ 0\\.01702616679969919\ \(0\)\
\-\ endovascular\\:\\ 0\\.016823215475367206\ \(0\)\
\-\ radical\\:\\ 0\\.016823215475367206\ \(0\)\
\-\ approximately\\:\\ 0\\.016627785072676624\ \(0\)\
\-\ treated\\:\\ 0\\.016087112176628046\ \(0\)\
\-\ widened\\:\\ 0\\.01596807800529286\ \(0\)\
\-\ ultimately\\:\\ 0\\.015682003231061017\ \(0\)\
\-\ 3\\.5\\:\\ 0\\.015682003231061017\ \(0\)\
\-\ obese\\:\\ 0\\.015548167965593107\ \(0\)\
\-\ considerations\\:\\ 0\\.015483327439798338\ \(0\)\
\-\ syndrome\\:\\ 0\\.01537048161468328\ \(0\)\
\-\ shadow\\:\\ 0\\.015296461337688902\ \(0\)\
\-\ region\\:\\ 0\\.015179881932322722\ \(0\)\
\-\ this\\:\\ 0\\.015112220335127878\ \(0\)\
\-\ mechanical\\:\\ 0\\.014846458684730812\ \(0\)\
\-\ months\\:\\ 0\\.014678876067233127\ \(0\)\
\-\ infiltrating\\:\\ 0\\.014594752056826607\ \(0\)\
\-\ 43\\:\\ 0\\.01449945221564633\ \(0\)\
\-\ dizziness\\:\\ 0\\.014406955721286915\ \(0\)\
\-\ differentiated\\:\\ 0\\.014361708119236287\ \(0\)\
\-\ percutaneous\\:\\ 0\\.01422974522898776\ \(0\)\
\-\ right\\:\\ 0\\.01417659919984932\ \(0\)\
\-\ \\=\\:\\ 0\\.014103097747421911\ \(0\)\
\-\ tip\\:\\ 0\\.013788369890324479\ \(0\)\
\-\ sarcoid\\:\\ 0\\.013788369890324479\ \(0\)\
\-\ \\(\\:\\ 0\\.013629466532903029\ \(0\)\
\-\ combination\\:\\ 0\\.013536663262420279\ \(0\)\
\-\ \\)\\:\\ 0\\.013462975322892548\ \(0\)\
\-\ occlusion\\:\\ 0\\.013401388466559616\ \(0\)\
\-\ episodes\\:\\ 0\\.013271693628402229\ \(0\)\
\-\ poorly\\:\\ 0\\.013116753222720523\ \(0\)\
\-\ right\\-sided\\:\\ 0\\.013116753222720523\ \(0\)\
\-\ place\\:\\ 0\\.013056853238535948\ \(0\)\
\-\ bilateral\\:\\ 0\\.013042878800719774\ \(0\)\
\-\ granulomatous\\:\\ 0\\.012969089753891053\ \(0\)\
\-\ upper\\:\\ 0\\.012969059782193197\ \(0\)\
\-\ mediastinum\\:\\ 0\\.012940371252119755\ \(0\)\
\-\ homogeneous\\:\\ 0\\.012719603143084382\ \(0\)\
\-\ ductal\\:\\ 0\\.01266675056976243\ \(0\)\
\-\ current\\:\\ 0\\.012589100844635473\ \(0\)\
\-\ local\\:\\ 0\\.012343299672153286\ \(0\)\
\-\ subsequently\\:\\ 0\\.012182000004267906\ \(0\)\
\-\ arch\\:\\ 0\\.012093412340850622\ \(0\)\
\-\ apparent\\:\\ 0\\.011882282457713425\ \(0\)\
\-\ admission\\:\\ 0\\.01184170571294642\ \(0\)\
\-\ per\\:\\ 0\\.01176208996456815\ \(0\)\
\-\ demonstrates\\:\\ 0\\.011739755985240165\ \(0\)\
\-\ absent\\:\\ 0\\.011646322753490425\ \(0\)\
\-\ infectious\\:\\ 0\\.011553002727873705\ \(0\)\
\-\ via\\:\\ 0\\.011534666500481275\ \(0\)\
\-\ cxr\\:\\ 0\\.011339724123034835\ \(0\)\
\-\ distress\\:\\ 0\\.011322587001124254\ \(0\)\
\-\ absence\\:\\ 0\\.011172415833527084\ \(0\)\
\-\ placement\\:\\ 0\\.010906952494493805\ \(0\)\
\-\ aortic\\:\\ 0\\.010877145123567565\ \(0\)\
\-\ filling\\:\\ 0\\.010818364831076519\ \(0\)\
\-\ vessels\\:\\ 0\\.010818364831076519\ \(0\)\
\-\ \\#\\:\\ 0\\.010539895028116001\ \(0\)\
\-\ process\\:\\ 0\\.010346117876838725\ \(0\)\
\-\ result\\:\\ 0\\.010308755210528183\ \(0\)\
\-\ radiographic\\:\\ 0\\.010199259093675264\ \(0\)\
\-\ course\\:\\ 0\\.010140035985709565\ \(0\)\
\-\ greater\\:\\ 0\\.010093447665630507\ \(0\)\
\-\ defect\\:\\ 0\\.010058953856289079\ \(0\)\
\-\ breast\\:\\ 0\\.00991370422588224\ \(0\)\
\-\ diagnosed\\:\\ 0\\.009881116845267313\ \(0\)\
\-\ wbc\\:\\ 0\\.00979583286344595\ \(0\)\
\-\ dilated\\:\\ 0\\.009764438385508266\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.009631904984719702\ \(0\)\
\-\ would\\:\\ 0\\.00956278892585563\ \(0\)\
\-\ obstruction\\:\\ 0\\.009476100781727784\ \(0\)\
\-\ complete\\:\\ 0\\.00945715702511338\ \(0\)\
\-\ \\&\\:\\ 0\\.00943832670484727\ \(0\)\
\-\ was\\:\\ 0\\.009323372851072516\ \(0\)\
\-\ in\\:\\ 0\\.009276039657175422\ \(0\)\
\-\ given\\:\\ 0\\.009211994945019945\ \(0\)\
\-\ inferior\\:\\ 0\\.00911734704829894\ \(0\)\
\-\ swelling\\:\\ 0\\.008952235421324317\ \(0\)\
\-\ initial\\:\\ 0\\.008904346362513547\ \(0\)\
\-\ flow\\:\\ 0\\.008880672568737473\ \(0\)\
\-\ superior\\:\\ 0\\.008580955022182993\ \(0\)\
\-\ past\\:\\ 0\\.00853836311932841\ \(0\)\
\-\ differential\\:\\ 0\\.008531320218090974\ \(0\)\
\-\ frontal\\:\\ 0\\.008441169605293578\ \(0\)\
\-\ days\\:\\ 0\\.00823608269236471\ \(0\)\
\-\ yo\\:\\ 0\\.008086011079568434\ \(0\)\
\-\ patient\\:\\ 0\\.008081055952041396\ \(0\)\
\-\ 6\\:\\ 0\\.008025535098663127\ \(0\)\
\-\ neck\\:\\ 0\\.007890701688737367\ \(0\)\
\-\ level\\:\\ 0\\.007744934049204189\ \(0\)\
\-\ lymphoma\\:\\ 0\\.007679869919463792\ \(0\)\
\-\ axial\\:\\ 0\\.007669155585119093\ \(0\)\
\-\ \\,\\:\\ 0\\.007661605627847757\ \(0\)\
\-\ through\\:\\ 0\\.007631940309499588\ \(0\)\
\-\ carcinoma\\:\\ 0\\.007616124748477568\ \(0\)\
\-\ edema\\:\\ 0\\.0076003883315449395\ \(0\)\
\-\ include\\:\\ 0\\.007538218515818512\ \(0\)\
\-\ ct\\:\\ 0\\.007517633040201528\ \(0\)\
\-\ secondary\\:\\ 0\\.007512672850656627\ \(0\)\
\-\ 4\\:\\ 0\\.007487333035154231\ \(0\)\
\-\ presented\\:\\ 0\\.007325024009504432\ \(0\)\
\-\ been\\:\\ 0\\.007310675753031419\ \(0\)\
\-\ than\\:\\ 0\\.007041034134963126\ \(0\)\
\-\ prior\\:\\ 0\\.006899725698749571\ \(0\)\
\-\ over\\:\\ 0\\.006841643365220008\ \(0\)\
\-\ consistent\\:\\ 0\\.00658898826676479\ \(0\)\
\-\ into\\:\\ 0\\.006394108075344991\ \(0\)\
\-\ \\;\\:\\ 0\\.006369249020291175\ \(0\)\
\-\ tissue\\:\\ 0\\.006369249020291175\ \(0\)\
\-\ without\\:\\ 0\\.006327085428799247\ \(0\)\
\-\ 3\\:\\ 0\\.006292375870146352\ \(0\)\
\-\ woman\\:\\ 0\\.006207241973235554\ \(0\)\
\-\ the\\:\\ 0\\.006086446496386041\ \(0\)\
\-\ had\\:\\ 0\\.005798269871826127\ \(0\)\
\-\ findings\\:\\ 0\\.005719613005628804\ \(0\)\
\-\ multiple\\:\\ 0\\.005659767306538581\ \(0\)\
\-\ female\\:\\ 0\\.005524403369332811\ \(0\)\
\-\ a\\:\\ 0\\.0049886767524352366\ \(0\)\
\-\ of\\:\\ 0\\.004762733994886319\ \(0\)\
\-\ and\\:\\ 0\\.004528528446093546\ \(0\)\
\-\ disease\\:\\ 0\\.004392256418917309\ \(0\)\
\-\ to\\:\\ 0\\.004028944419273455\ \(0\)\
\-\ history\\:\\ 0\\.003711366470776992\ \(0\)\
\-\ at\\:\\ 0\\.003640764631546016\ \(0\)\
\-\ with\\:\\ 0\\.0033114389459402756\ \(0\)\
\-\ left\\:\\ 0\\.003006620343625518\ \(0\)\
\-\ no\\:\\ 0\\.002705799216049692\ \(0\)\
\-\ for\\:\\ 0\\.0022927929202601104\ \(0\)\
\-\ \\.\\:\\ 0\\.001674506419686145\ \(0\)\
